Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 24, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 24, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/23/17 - 22nd Century Receives Guidance from FDA on Phase III Clinical Trials [Tehran Times (Iran)]
22nd Century Group, Inc., a plant biotechnology company that is a leader in tobacco harm reduction, announced today that on June 20, 2017, the Company and its wholly owned subsidiary, Heracles Pharmaceuticals, participated in a meeting with the multi-discipline review team in the Division of Anesthesia, Analgesia, and Addiction Products at the Cent
6/23/17 - Abbott Laboratories' Trademark Application for "PRO SCIENCE PUSH" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE PUSH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe, A
6/23/17 - AbbVie Announces Pivotal Phase 2 Trial Evaluating VENCLYXTO? (venetoclax) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion to be Presented at 22nd European Hematology Association (EHA) Annual Congress
AbbVie, a global biopharmaceutical company, today announced the presentation of results from the pivotal Phase 2 study of VENCLYXTO?, a first-in-class oral B-cell lymphoma-2 inhibitor. VENCLYXTO monotherapy was granted conditional marketing authorization in the EU for the treatment of CLL in the presence of 17 p deletion or TP53 mutation in adu
6/23/17 - AbbVie Receives CHMP Positive Opinion for MAVIRET? (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
AbbVie, a global biopharmaceutical company, today announced that the European Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion recommending marketing authorization of MAVIRET?, an investigational, pan-genotypic treatment for adults with chronic hepatitis C virus infection.
6/23/17 - Academy of Managed Care Pharmacy (AMCP) Partnership Forum Attendees Create Action Plans to Advance Value-Based Contracting
ALEXANDRIA, Va., June 23, 2017/ PRNewswire-USNewswire/ Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of "value-based contracting." The Academy of Managed Care Pharmacy Partnership Forum, Advancing..
6/23/17 - Acceleron Provides Updated Results from Ongoing Phase 2 Study of Luspatercept in Myelodysplastic Syndromes at the 22nd Congress of the European Hematology Association
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics to treat serious and rare diseases, today announced preliminary results from the ongoing Phase 2 studies of luspatercept in patients with lower-risk myelodysplastic syndromes at the 22 nd Congress
6/23/17 - Acceleron Provides Updated Results from Phase 2 Studies of Luspatercept in Beta-Thalassemia at the 22nd Congress of the European Hematology Association
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics to treat serious and rare diseases, today announced preliminary results from the ongoing Phase 2 study of luspatercept in patients with beta-thalassemia during an oral presentation at the 22 nd...
6/23/17 - Advanced Infusion Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024
The key factors that are driving the advanced infusion systems market are the overall growth in the global population that are suffering from diabetes, cancer, and chronic disease.Sarasota, FL 06/22/2017 Zion Market Research, the market research group announced the analysis report titled " Advanced Infusion Systems Market: Global Industry Ana
6/23/17 - Akari Therapeutics to Present Data from Phase 2 PNH Trial of Coversin at the 22nd Congress of the European Hematology Association
Akari Therapeutics, a clinical-stage biopharmaceutical company, is presenting a poster today at the 22nd Congress of the European Hematology Association in Madrid, Spain containing data for the four patients, to date, who have completed its ongoing Phase 2 trial of Coversin in paroxysmal nocturnal hemoglobinuria. Coversin is a second-generation..
6/23/17 - Alcobra Updates on its Review of Strategic Alternatives
Alcobra Ltd., an emerging pharmaceutical company focused on the development of new medications to treat significant unmet clinical needs, today announced that its Board of Directors is conducting a process to explore and review a range of strategic alternatives focused on maximizing stockholder value from its development assets and cash resources
6/23/17 - Alexion Receives Positive CHMP Opinion for Soliris (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) in the European Union
Alexion Pharmaceuticals, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to extend the current therapeutic indication for Soliris to include the treatment of refractory generalized myasthenia gravis in patients who are anti-acetylcholine receptor...
6/23/17 - Allantoin Market Is Expected To Witness Growth Swiftly Based On Rising Demand From Various Application Such As Cosmetics And Pharmaceutical Till 2022: Grand View Research, Inc
According to report published by Grand View Research, Global Allantoin Market is expected to reach USD 641.7 million by 2022. Growing application scope of allantoin in pharmaceutical industry is anticipated to drive market growth over the forecast period. Global Allantoin Market is expected to reach USD 641.7 million by 2022, according to a new stu
6/23/17 - Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara (cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Certain Children With End-Stage Renal Disease On Dialysis
THOUSAND OAKS, Calif., June 23, 2017/ PRNewswire/ Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the Marketing Authorization of a pediatric formulation of Mimpara . The CHMP positive opinion will now be reviewed by the European Commission, which h
6/23/17 - Amid Reports that Trump Will Break Promise to Get Tough on Drug Pricing, Booker, Franken, Lawmakers Urge Trump to Act on Solutions that Bring Down...
Washington, DC- With news reports indicating the White House is on the verge of issuing an executive order devoid of policies that would meaningfully reduce prescription drug prices, breaking yet another key promise to Americans, Sen. Cory Booker joined Sen. Al Franken and other Senate and House Democrats to urge President Donald Trump to act on so
6/23/17 - An Application for the Trademark "ENSURE HEALTHY MATTERS" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENSURE HEALTHY MATTERS" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona,
6/23/17 - An Application for the Trademark "PRO SCIENCE FINISH" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE FINISH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe,
6/23/17 - Another View Drug importation would worsen the opioid crisis
Bernie Sanders is sponsoring a bill that would allow people to import packages of prescription drugs from Canada. Maggie Hassan, New Jersey Sen. Cory Booker, and Minnesota Sen. Al Franken also support the bill.
6/23/17 - Anti-tumor Activity Observed in Phase 1 Trial of Novel P53-Targeting Drug ALRN-6924
By a News Reporter-Staff News Editor at Drug Week Aileron Therapeutics, a clinical-stage biopharmaceutical company developing a novel class of therapeutics called stapled peptides, announced safety and clinical activity data, including complete responses, partial responses and evidence of stable disease, from its Phase 1, multi-center trial with.
6/23/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report (Jun. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on June 2, 2017. The SEC file number is 0001171843-17-003427.. A U.S. Securities and Exchange Commission filing is a formal d
6/23/17 - As White House Prepares Gift to Big Pharma, Rep. Schakowsky and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down...
Schakowsky and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Rep. Jan Schakowsky, a Chief Deputy Whip, led a wide group of House and Senate Democrats i
6/23/17 - As White House Prepares Gift to Big Pharma, Sen. Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription...
Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedly favors the industry over consumers, Sen. Al Franken led a wide group of Senate and House Democrats in pushing President Donald Tr
6/23/17 - Aspen Spotlight Health 360 degree Video Premiere: New Virtual Reality Video Takes You Inside the Lab with Researchers to Showcase Amazing Advancements in Medicine
The Pharmaceutical Research and Manufacturers of America issued the following news release:. America's biopharmaceutical companies released a new virtual reality video highlighting innovation and a new era of groundbreaking advancements today to kick off Spotlight Health, the opening segment of the annual 2017 Aspen Ideas Festival.
6/23/17 - Astellas president wants people to focus on lives saved by pharmaceutical industry [Chicago Tribune]
June 22 Jim Robinson just wrapped up his first year as president of Astellas Americas and it was quite a year for the pharmaceutical industry. Robinson, 47, is based in Northbrook, where he heads North and South American operations for Japanese drugmaker Astellas Pharma. A: Mark Kaufman and Mary Ann Kaufman, his wife, are responsible for me bei
6/23/17 - AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma
AVEO Oncology today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has recommended FOTIVDA? for approval as a treatment for patients with advanced renal cell carcinoma. The CHMP's recommendation is now referred to the European Commission. Mr. Bailey concluded: If th
6/23/17 - AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Files An 8-K Other Events
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Files An 8-K Other Events Item8.01. Other Events. On June23, 2017, AVEO Pharmaceuticals, Inc. (the Company) issued a press release announcing that the Committee for Medicinal Products for Human Use of the European Medicines Agency made a decision with respect to the marketing authorization application for ti
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415